Nine Months Ended September 30, 2020 and 2019
| Nine Months Ended September 30, | |||||||
| (in thousands) | 2020 | 2019 | |||||
| Cash flows from operating activities: | |||||||
| Net loss | $ | (129,764 | ) | $ | (64,972 | ) | |
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||||
| Depreciation and amortization | 34,830 | 39,305 | |||||
| Stock-based compensation | 16,621 | 19,221 | |||||
| Provision for inventory obsolescence and revaluation | 10,894 | — | |||||
| Loss on hedge accounting de-designation | 1,235 | — | |||||
| Provision for bad debts | 1,039 | 1,152 | |||||
| Loss on the disposition of property, equipment and other assets | 434 | 1,620 | |||||
| Provision for deferred income taxes | — | (1,346 | ) | ||||
| Impairment of goodwill and assets | 54,072 | 1,728 | |||||
| Changes in operating accounts: | |||||||
| Accounts receivable | 12,668 | 12,290 | |||||
| Inventories | (23,987 | ) | 6,481 | ||||
| Prepaid expenses and other current assets | (15,376 | ) | (3,122 | ) | |||
| Accounts payable | (9,166 | ) | (12,885 | ) | |||
| Deferred revenue and customer deposits | 2,714 | 4,491 | |||||
| Accrued and other current liabilities | 6,309 | 1,199 | |||||
| All other operating activities | 4,828 | 4,922 | |||||
| Net cash (used in) provided by operating activities | (32,649 | ) | 10,084 | ||||
| Cash flows from investing activities: | |||||||
| Purchases of property and equipment | (11,015 | ) | (18,265 | ) | |||
| Proceeds from sale of assets | 552 | 1,620 | |||||
| Purchase of noncontrolling interest | (12,500 | ) | (2,500 | ) | |||
| Other investing activities | 504 | (1,744 | ) | ||||
| Net cash used in investing activities | (22,459 | ) | (20,889 | ) | |||
| Cash flows from financing activities: | |||||||
| Proceeds from revolving credit facilities | 20,000 | — | |||||
| Payments on revolving credit facilities | (20,000 | ) | — | ||||
| Proceeds from borrowings/long-term debt | — | 100,000 | |||||
| Repayment of borrowings/long-term debt | (26,547 | ) | (66,013 | ) | |||
| Proceeds from issuance of common stock | 25,003 | — | |||||
| Proceeds from inventory financing agreements | 2,509 | — | |||||
| Payments related to net-share settlement of stock-based compensation | (5,034 | ) | (3,029 | ) | |||
| Other financing activities | 296 | (1,125 | ) | ||||
| Net cash (used in) provided by financing activities | (3,773 | ) | 29,833 | ||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 526 | (1,400 | ) | ||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | (58,355 | ) | 17,628 | ||||
| Cash, cash equivalents and restricted cash at the beginning of the period (a) | 134,617 | 110,919 | |||||
| Cash, cash equivalents and restricted cash at the end of the period (a) | $ | 76,262 | $ | 128,547 | |||
